Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Avalo Therapeutics, Inc. | cercex-3212019.htm |
| EX-31.2 - EXHIBIT 31.2 - Avalo Therapeutics, Inc. | cercex-3122019.htm |
| EX-31.1 - EXHIBIT 31.1 - Avalo Therapeutics, Inc. | cercex-3112019.htm |
| EX-21.1 - EXHIBIT 21.1 - Avalo Therapeutics, Inc. | cercex-2112019.htm |
| EX-10.32 - EXHIBIT 10.32 - Avalo Therapeutics, Inc. | ex-1032assignmentoflicense.htm |
| EX-10.15.2 - EXHIBIT 10.15.2 - Avalo Therapeutics, Inc. | ex-10152amendmenttoharrell.htm |
| EX-4.10 - EXHIBIT 4.10 - Avalo Therapeutics, Inc. | ex-410descriptionofregiste.htm |
| 10-K - 10-K - Avalo Therapeutics, Inc. | cerc10-k20191231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm |
We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statement (Form S-1 No. 333-204905) as filed on June 12, 2015, and amended on September 8, 2015, September 22, 2015, October 1, 2015, and October 13, 2015, (2) Registration Statement (Form S-8 No. 333-207949) pertaining to the 2015 Omnibus Incentive Compensation Plan, (3) Registration Statement (Form S-8 No. 333-211490) pertaining to the 2016 Equity Incentive Plan, (4) Registration Statement (Form S-8 No. 333-211491) pertaining to the 2016 Employee Stock Purchase Plan, (5) Registration Statement (Form S-1 No. 333-213676) as filed on September 16, 2016, (6) Registration Statement (Form S-3 No. 333-214507) as filed on November 8, 2016, and amended on December 1, 2016, (7) Registration Statement (Form S-3 No. 333-218252) as filed on May 26, 2017, (8) Registration Statement (Form S-8 No. 333-226767) pertaining to the Amended and Restated 2016 Equity Incentive Plan, (9) Registration Statement (Form S-3 No. 333-227227) as filed on September 7, 2018, and amended on October 2, 2018, (10) Registration Statement (Form S-3 No. 333-229283) as filed on January 17, 2019, (11) Registration Statement (Form S-3 No. 333-233978) filed on September 27, 2019, and amended on October 18, 2019, and (12) Registration Statement (Form S-4 No. 333-235666) filed on December 20, 2019 and amended on December 30, 2019; of our report dated March 11, 2020, with respect to the consolidated financial statements of Cerecor Inc. and subsidiaries included in this Annual Report (Form 10-K) of Cerecor Inc. for the year ended December 31, 2019. |
Baltimore, Maryland
March 11, 2020